INFINIUM — Infinium Pharmachem Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsAdventurousMicro CapHigh Flyer

Annual income statement for Infinium Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	991	1,142	1,356	1,557	1,896
Cost of Revenue
Gross Profit	224	337	314	368	398
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	897	995	1,198	1,398	1,711
Operating Profit	94	147	159	159	185
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	86.3	130	152	116	178
Provision for Income Taxes
Net Income After Taxes	66.9	98.2	115	78.4	142
Minority Interest
Net Income Before Extraordinary Items
Net Income	61.1	94.9	113	81.5	122
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	61.1	94.9	113	81.5	122
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	4.39	9.33	8.12	6.9	7.8